• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国移植学会会议关于美国成人心脏移植中供心选择的报告。

Report From the American Society of Transplantation Conference on Donor Heart Selection in Adult Cardiac Transplantation in the United States.

机构信息

Cedars-Sinai Heart Institute, Los Angeles, CA.

Stanford University, Stanford, CA.

出版信息

Am J Transplant. 2017 Oct;17(10):2559-2566. doi: 10.1111/ajt.14354. Epub 2017 Jun 13.

DOI:10.1111/ajt.14354
PMID:28510318
Abstract

Cardiac transplantation remains the only definitive treatment for end-stage heart failure. Transplantation rates are limited by a shortage of donor hearts. This shortage is magnified because many hearts are discarded because of strict selection criteria and concern for regulatory reprimand for less-than-optimal posttransplant outcomes. There is no standardized approach to donor selection despite proposals to liberalize acceptance criteria. A donor heart selection conference was organized to facilitate discussion and generate ideas for future research. The event was attended by 66 participants from 41 centers with considerable experience in cardiac donor selection. There were state-of-the-art presentations on donor selection, with subsequent breakout sessions on standardizing the process and increasing utilization of donor hearts. Participants debated misconceptions and established agreement on donor and recipient risk factors for donor selection and identified the components necessary for a future donor risk score. Ideas for future initiatives include modification of regulatory practices to consider extended criteria donors when evaluating outcomes and prospective studies aimed at identifying the factors leading to nonacceptance of available donor hearts. With agreement on the most important donor and recipient risk factors, it is anticipated that a consistent approach to donor selection will improve rates of heart transplantation.

摘要

心脏移植仍然是治疗终末期心力衰竭的唯一有效方法。由于供体心脏短缺,移植率受到限制。由于严格的选择标准以及对移植后结果不如理想时的监管处罚的担忧,许多心脏被丢弃,这使得短缺情况更加严重。尽管有提议放宽接受标准,但仍没有标准化的供体选择方法。组织了一次供体心脏选择会议,以促进讨论并为未来的研究提供思路。来自 41 个中心的 66 名参与者参加了此次会议,他们在心脏供体选择方面拥有丰富的经验。会上就供体选择进行了最先进的演示,随后就标准化流程和增加供体心脏的利用进行了分组讨论。与会者对误解进行了辩论,并就供体和受体选择供体的风险因素达成了一致意见,并确定了未来供体风险评分所需的组成部分。未来举措的想法包括修改监管实践,在评估结果时考虑扩展标准供体,以及旨在确定导致不可接受的可用供体心脏的因素的前瞻性研究。随着对最重要的供体和受体风险因素的一致意见,预计一致的供体选择方法将提高心脏移植的比例。

相似文献

1
Report From the American Society of Transplantation Conference on Donor Heart Selection in Adult Cardiac Transplantation in the United States.美国移植学会会议关于美国成人心脏移植中供心选择的报告。
Am J Transplant. 2017 Oct;17(10):2559-2566. doi: 10.1111/ajt.14354. Epub 2017 Jun 13.
2
National decline in donor heart utilization with regional variability: 1995-2010.1995 - 2010年全国供体心脏利用率下降且存在地区差异
Am J Transplant. 2015 Mar;15(3):642-9. doi: 10.1111/ajt.13055. Epub 2015 Feb 10.
3
Potential for donation after circulatory death heart transplantation in the United States: Retrospective analysis of a limited UNOS dataset.美国循环死亡后心脏移植的捐赠潜力:对有限 UNOS 数据集的回顾性分析。
Am J Transplant. 2020 Feb;20(2):525-529. doi: 10.1111/ajt.15597. Epub 2019 Oct 28.
4
Great variability in donor heart acceptance practices across the United States.美国各地在供体心脏接受标准方面存在巨大差异。
Am J Transplant. 2020 Jun;20(6):1582-1596. doi: 10.1111/ajt.15760. Epub 2020 Jan 20.
5
Current Use of Hearts From Hepatitis C Viremic Donors.丙型肝炎病毒感染者心脏的使用现状。
Circ Heart Fail. 2018 Dec;11(12):e005276. doi: 10.1161/CIRCHEARTFAILURE.118.005276.
6
Assessment of potential heart donors: A statement from the French heart transplant community.潜在心脏供体评估:法国心脏移植协会的声明。
Arch Cardiovasc Dis. 2018 Feb;111(2):126-139. doi: 10.1016/j.acvd.2017.12.001. Epub 2017 Dec 23.
7
Donation After Cardiac Death: A Necessary Expansion for Heart Transplantation.心死亡后捐献:心脏移植的必要拓展。
Semin Thorac Cardiovasc Surg. 2019;31(4):721-725. doi: 10.1053/j.semtcvs.2019.05.010. Epub 2019 May 16.
8
Impact of low donor to recipient weight ratios on cardiac transplantation.供体与受体体重比低对心脏移植的影响。
J Thorac Cardiovasc Surg. 2013 Dec;146(6):1538-43. doi: 10.1016/j.jtcvs.2013.06.028. Epub 2013 Aug 1.
9
New Strategies to Expand and Optimize Heart Donor Pool: Ex Vivo Heart Perfusion and Donation After Circulatory Death: A Review of Current Research and Future Trends.拓展和优化心脏供体库的新策略:体外心脏灌注和循环死亡后捐献:对当前研究和未来趋势的综述。
Anesth Analg. 2019 Mar;128(3):406-413. doi: 10.1213/ANE.0000000000003919.
10
Changing demographics of heart donors: The impact of donor drug intoxication on posttransplant survival.心脏供体人口统计学的变化:供体药物中毒对移植后存活的影响。
Am J Transplant. 2018 Jul;18(7):1790-1798. doi: 10.1111/ajt.14726. Epub 2018 Apr 2.

引用本文的文献

1
Outcomes of donation after brain death heart transplantation from older donors: A contemporary analysis of the UNOS database.老年供体脑死亡后心脏移植的结果:对器官共享联合网络(UNOS)数据库的当代分析
JHLT Open. 2025 Jun 4;9:100313. doi: 10.1016/j.jhlto.2025.100313. eCollection 2025 Aug.
2
Analysis of survival impact factors in heart transplant patients with modified donor hearts preservation method.采用改良供心保存方法的心脏移植患者生存影响因素分析
BMC Cardiovasc Disord. 2025 Jul 3;25(1):450. doi: 10.1186/s12872-025-04886-3.
3
Cocultured amniotic stem cells and cardiomyocytes in a 3-D acellular heart patch reduce the infarct size and left ventricle remodeling: promote angiogenesis in a porcine acute myocardial infarction model.
在三维脱细胞心脏补片中共培养的羊膜干细胞和心肌细胞可减小梗死面积并减轻左心室重构:在猪急性心肌梗死模型中促进血管生成。
J Cardiothorac Surg. 2025 May 9;20(1):229. doi: 10.1186/s13019-025-03453-3.
4
Predictive scoring systems for mortality in heart transplant patients with liver cirrhosis.肝硬化心脏移植患者死亡率的预测评分系统。
Sci Rep. 2025 Apr 12;15(1):12663. doi: 10.1038/s41598-025-87675-4.
5
Prediction of Donor Heart Acceptance for Transplant and Its Clinical Implications: Results From The Donor Heart Study.供心接受移植的预测及其临床意义:来自供心研究的结果。
Circ Heart Fail. 2024 Oct;17(10):e011360. doi: 10.1161/CIRCHEARTFAILURE.123.011360. Epub 2024 Sep 23.
6
Outcomes of Heart Transplant Using High Donor Sequence Number Offers.高供体序列数的心脏移植结局。
J Surg Res. 2024 Aug;300:325-335. doi: 10.1016/j.jss.2024.05.008. Epub 2024 Jun 4.
7
Recipient Pericardial Apolipoprotein Levels Might Be an Indicator of Worse Outcomes after Orthotopic Heart Transplantation.受体心包脂类载脂蛋白水平可能是原位心脏移植后预后不良的一个指标。
Int J Mol Sci. 2024 Feb 1;25(3):1752. doi: 10.3390/ijms25031752.
8
Impact of prolonged cardiopulmonary resuscitation on outcomes in heart transplantation with higher risk donor heart.高风险供心心脏移植中长时间心肺复苏对结局的影响。
Gen Thorac Cardiovasc Surg. 2024 Jul;72(7):455-465. doi: 10.1007/s11748-023-01990-z. Epub 2024 Jan 5.
9
Up to an Hour of Donor Resuscitation Does Not Affect Pediatric Heart Transplantation Survival.供体复苏长达 1 小时不会影响儿科心脏移植的存活率。
Ann Thorac Surg. 2024 Mar;117(3):611-618. doi: 10.1016/j.athoracsur.2023.04.043. Epub 2023 Jun 3.
10
Rethinking Donor and Recipient Risk Matching in Europe and North America: Using Heart Transplant Predictors of Donor and Recipient Risk.重新思考欧洲和北美的供体和受体风险匹配:使用心脏移植预测供体和受体风险。
Circ Heart Fail. 2023 May;16(5):e009994. doi: 10.1161/CIRCHEARTFAILURE.122.009994. Epub 2023 May 16.